Please login to the form below

Not currently logged in
Email:
Password:

MyCite

This page shows the latest MyCite news and features for those working in and with pharma, biotech and healthcare.

Four digital health trends set to reinvent and re-energise pharma

Four digital health trends set to reinvent and re-energise pharma

For example, Abilify MyCite is the first ‘digital medicine’ approved by the FDA in the US.

Latest news

  • First digital medicine approved in the US First digital medicine approved in the US

    The antipsychotic drug has a built-in digital tracking sensor. The FDA has approved Otsuka and Proteus Health’s Abilify MyCite, a pill with an embedded sensor that monitors whether patients ... Abilify MyCite is the latest iteration of antipsychotic

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....